Related Experiment Videos
Predicting new molecular targets for rhein using network pharmacology
Aihua Zhang1, Hui Sun, Bo Yang
1National TCM Key Lab of Serum Pharmacochemistry, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China.
BMC Systems Biology
|March 22, 2012
Summary
This study introduces a computational method using network pharmacology to predict drug targets for rhein. The approach identified key genes involved in various biological processes, aiding drug discovery.
Area of Science:
- Computational biology and network pharmacology.
- Drug discovery and target identification.
Background:
- Drug-target interactions are crucial for understanding biological systems and identifying new therapeutic strategies.
- Existing drug-target datasets are limited, necessitating advanced computational methods for accurate prediction.
- Network pharmacology offers a scalable approach to analyze biological systems and predict drug activity.
Purpose of the Study:
- To develop and present a computational method for predicting rhein (rhein) targets by analyzing drug-reaction interactions.
- To leverage integrated data sources for comprehensive drug-target interaction network construction.
- To facilitate the drug discovery pipeline through accurate target identification.
Main Methods:
- Implemented a computational platform integrating pathway, protein-protein interaction, differentially expressed genome, and literature mining data.
- Constructed comprehensive networks for drug-target interaction analysis.
- Utilized Cytoscape software for predicting rhein-target interactions.
Main Results:
- Identified 3 differentially expressed genes as central nodes in a complex interaction network (99 nodes, 153 edges) using Cytoscape.
- The predicted rhein targets are involved in critical biological processes including immunity, apoptosis, transport, signal transduction, cell growth, and metabolism.
- The method successfully predicted potential drug targets for rhein.
Conclusions:
- Network pharmacology accelerates the identification of drug targets and reveals new applications for existing drugs.
- The study highlights the significant contribution of network pharmacology in predicting drug targets.
- The findings support the utility of computational methods in advancing drug discovery.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: